XML 22 R9.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Statements of Operations - WES Operating (Parenthetical) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Total revenues and other [1] $ 1,224,719 $ 942,322 $ 2,348,298 $ 1,859,438
Total operating expenses [2] 714,954 524,060 1,377,749 1,047,141
Related Parties [Member]        
Total revenues and other 570,024 576,247 1,131,483 1,134,649
Total operating expenses 40,967 (7,289) 36,366 (19,351)
WES Operating [Member]        
Total revenues and other [3] 1,224,719 942,322 2,348,298 1,859,438
Total operating expenses [4] 714,251 523,759 1,376,701 1,047,028
WES Operating [Member] | Related Parties [Member]        
Total revenues and other 570,000 576,200 1,100,000 1,100,000
Total operating expenses $ 41,900 $ (6,400) $ 38,900 $ (17,000)
[1] Total revenues and other includes related-party amounts of $570.0 million and $1.1 billion for the three and six months ended June 30, 2026, respectively, and $576.2 million and $1.1 billion for the three and six months ended June 30, 2025, respectively. See Note 6.
[2] Total operating expenses includes related-party amounts of $41.0 million and $36.4 million for the three and six months ended June 30, 2026, respectively, and $(7.3) million and $(19.4) million for the three and six months ended June 30, 2025, respectively, all primarily related to changes in imbalance positions. See Note 6.
[3] Total revenues and other includes related-party amounts of $570.0 million and $1.1 billion for the three and six months ended June 30, 2026, respectively, and $576.2 million and $1.1 billion for the three and six months ended June 30, 2025, respectively. See Note 6.
[4] Total operating expenses includes related-party amounts of $41.9 million and $38.9 million for the three and six months ended June 30, 2026, respectively, and $(6.4) million and $(17.0) million for the three and six months ended June 30, 2025, respectively, all primarily related to changes in imbalance positions. See Note 6.